5% increase in sales
Symbol: CXG.A-CDNX
www.clemex.com
Shares Outstanding: 30,999,810
MONTREAL,
Sept. 11, 2012 /CNW Telbec/ - Clemex
Technologies Inc. (TSXV: CXG.A), designer and manufacturer of Image
Analysis systems and software for microscopy applications,
announces its financial results for the first Quarter of FY2013
ending July 31, 2012. For this first
Quarter, sales reached $1,305,152 an
increase of $64,322 or 5% compared to
the same period last year. The Corporation ends this quarter with a
Net Loss of $44,265 compared to a Net
Loss of $46,247 posted last year.
During this past Quarter, the Corporation made
several sales to clients in the manufacturing sector in
North America: NUCOR Steel Mills,
Blytheville Arkansas, NSL Central
Testing, Cleveland Ohio,
University of Toronto, Toronto Ontario and McMaster University, Hamilton Ontario. On the International
side, substantial sales were made to Tenaris Silcotub in
Romania, Renk Zanini, Brazil and Nano S-Tech in South Korea.
FINANCIAL HIGHLIGHTS
|
|
First Quarter July 31 |
| |
Fiscal Year |
2012 |
2011 |
| |
|
$ |
$ |
| Sales |
|
1,305,152 |
1,240,830 |
| |
|
|
|
| Gross Margin |
|
664,866 |
668,172 |
| Gross Margin % |
|
50.9% |
53.8% |
| Total Operating Expenses |
|
681 131 |
686 419 |
| |
|
|
|
| Income Taxes |
|
28,000 |
28,000 |
| |
|
|
|
| Net Loss |
|
(44,265) |
(46,247) |
| |
|
|
|
| Net Loss per share |
|
(0.001) |
(0.002) |
Clement Forget,
President and CEO of Clemex Technologies Inc. declared: "Given the
circumstances of the market, we are satisfied with our results for
this First Quarter of FY2013. Moreover this Quarter is always
slightly more difficult to manage because of the slowdown related
to summer vacation. The limited growth in the manufacturing sector
in Asia has also affected our
sales during this first Quarter. However, we have managed to keep
our Operating Expenses to the same level as last year in spite of a
growth of activities.
Mr. Forget continued:"We have recently concluded
a 1 M$ private investment from a German company, Zwick/Roell AG,
and this has reinforced our business partnership which already
existed. Now with two strong strategic partners, RAL
Diagnostics and Zwick/Roell AG, a healthier improved financial
position, we are able to pursue our developments projects in the
biomedical sector with enthusiasm."
The board has granted a total of 470,000 stock
options to board members and employees of the Company on
September 11th, 2012.
After this grant, a total of 1,634,981 stock options remain
available according to the total outstanding shares and the stock
option plan rules in force.
About Clemex Technologies, Inc.
Clemex Technologies Inc. develops, manufactures
and markets image analysis systems and software used by quality
control and research microscopy laboratories. Clemex's customer
base spans over many countries in America, Europe, Asia
and encompasses major Research and Development Centers, prestigious
Universities and large manufacturing industries in various fields
including healthcare, automotive, aerospace, raw materials
manufacturing, pharmaceuticals, mining and other sectors.
The CDNX has not reviewed and does not accept responsibility
for the adequacy and accuracy of this press release.
SOURCE CLEMEX TECHNOLOGIES INC.